These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27015836)

  • 1. Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.
    Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan U; Kukongviriyapan V
    Tumour Biol; 2016 Aug; 37(8):11495-507. PubMed ID: 27015836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway.
    Wandee J; Prawan A; Senggunprai L; Kongpetch S; Kukongviriyapan V
    Life Sci; 2019 Jan; 217():155-163. PubMed ID: 30528773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.
    Srijiwangsa P; Ponnikorn S; Na-Bangchang K
    BMC Pharmacol Toxicol; 2018 Jun; 19(1):32. PubMed ID: 29914576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway.
    Wandee J; Prawan A; Senggunprai L; Kongpetch S; Tusskorn O; Kukongviriyapan V
    Life Sci; 2018 Aug; 207():172-183. PubMed ID: 29847773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Nrf2 confers chemosensitizing effect through enhanced oxidant-mediated mitochondrial dysfunction.
    Sompakdee V; Prawan A; Senggunprai L; Kukongviriyapan U; Samathiwat P; Wandee J; Kukongviriyapan V
    Biomed Pharmacother; 2018 May; 101():627-634. PubMed ID: 29518609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
    Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
    Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells.
    Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan V
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):601-12. PubMed ID: 25708948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells.
    Buranrat B; Senggunprai L; Prawan A; Kukongviriyapan V
    Life Sci; 2016 May; 153():41-9. PubMed ID: 27098189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways.
    Chen Q; Li W; Wan Y; Xia X; Wu Q; Chen Y; Lai Z; Yu C; Li W
    Hepatology; 2012 Jun; 55(6):1820-9. PubMed ID: 22213475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.
    Tepsiri N; Chaturat L; Sripa B; Namwat W; Wongkham S; Bhudhisawasdi V; Tassaneeyakul W
    World J Gastroenterol; 2005 May; 11(18):2748-53. PubMed ID: 15884115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.
    Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M
    Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.
    Wang Z; Tang X; Zhang Y; Qi R; Li Z; Zhang K; Liu Z; Yang X
    Biomed Pharmacother; 2012 Apr; 66(3):161-6. PubMed ID: 22425181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents.
    Zeekpudsa P; Kukongviriyapan V; Senggunprai L; Sripa B; Prawan A
    J Exp Clin Cancer Res; 2014 Jan; 33(1):11. PubMed ID: 24460787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells.
    Nutthasirikul N; Hahnvajanawong C; Techasen A; Limpaiboon T; Leelayuwat C; Chau-In S; Jearanaikoon P
    Int J Oncol; 2015 Dec; 47(6):2153-64. PubMed ID: 26459801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.
    Buranrat B; Prawan A; Kukongviriyapan U; Kongpetch S; Kukongviriyapan V
    World J Gastroenterol; 2010 May; 16(19):2362-70. PubMed ID: 20480521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways.
    Prakobwong S; Gupta SC; Kim JH; Sung B; Pinlaor P; Hiraku Y; Wongkham S; Sripa B; Pinlaor S; Aggarwal BB
    Carcinogenesis; 2011 Sep; 32(9):1372-80. PubMed ID: 21325634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Proliferative Effects of Compound A and Its Effect in Combination with Cisplatin in Cholangiocarcinoma Cells.
    Junking M; Rattanaburee T; Panya A; Budunova I; Haegeman G; Yenchitsomanus PT
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2673-2681. PubMed ID: 32986368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells.
    Yang X; Wang S; Mu Y; Zheng Y
    Oncol Rep; 2016 Oct; 36(4):1799-806. PubMed ID: 27499090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells.
    Pratummanee K; Kerdkumthong K; Roytrakul S; Tantimetta P; Runsaeng P; Saeheng S; Obchoei S
    Mol Med Rep; 2024 Nov; 30(5):. PubMed ID: 39239747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of the EGFR - Targeting Compound 3-[(4-Phenylpyrimidin-2-yl) Amino] Benzene-1-Sulfonamide (13f) against Cholangiocarcinoma Cell Lines.
    Samatiwat P; Tabtimmai L; Suphakun P; Jiwacharoenchai N; Toviwek B; Kukongviriyapan V; Gleeson MP; Choowongkomon K
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):381-390. PubMed ID: 33639651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.